Clinical utility and prognostic value of GATA3 in epithelioid malignant mesothelioma: a practical and cost-effective approach for resource-limited settings
Journal of Clinical Pathology · 2026-07 · 79 (7) · 475-485
DOI: 10.1136/jcp-2026-210673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pathology, online erschienen am 14.05.2026. Verfasst von Dina Moustafa Thabit und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Minia University, Minia, Egypt dina.mostafa@mu.edu.eg. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, Biomarkers, Tumor, Mesothelioma, Malignant, Lung Neoplasms. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Aims
Distinguishing epithelioid malignant mesothelioma (EMM) from poorly differentiated lung adenocarcinoma (PD-LUAD) remains challenging, particularly when 21.7% of PD-LUADs lack lineage-specific markers (thyroid transcription factor-1 (TTF-1)/Napsin A), creating a diagnostic blind spot. While GATA-binding protein 3 (GATA3) is established in sarcomatoid mesothelioma, its complementary diagnostic value and prognostic relevance in EMM are not well defined.
Methods
This retrospective study analysed 115 tissue specimens (55 EMMs; 60 PD-LUADs). Immunohistochemistry for GATA3, calretinin, Wilms’ tumour gene 1 (WT-1), TTF-1, Napsin A and pan-cytokeratin was performed. Results were correlated with clinicopathological parameters and overall survival (OS) using Kaplan–Meier and multivariate Cox regression analyses.
Results
GATA3 was expressed in 78.2% of EMM but only 6.7% of PD-LUAD cases (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Faculty of Medicine, Minia University, Minia, Egypt dina.mostafa@mu.edu.eg.
- Department of Pathology, Faculty of Medicine, Minia University, Minia, Egypt.
Zitieren
APA
Thabit, D. M., & Thabet, D. M. (2026). Clinical utility and prognostic value of GATA3 in epithelioid malignant mesothelioma: a practical and cost-effective approach for resource-limited settings. Journal of Clinical Pathology, 79(7), 475-485. https://doi.org/10.1136/jcp-2026-210673
Vancouver
Thabit DM, Thabet DM. Clinical utility and prognostic value of GATA3 in epithelioid malignant mesothelioma: a practical and cost-effective approach for resource-limited settings. Journal of Clinical Pathology. 2026;79(7):475-485. doi:10.1136/jcp-2026-210673
BibTeX
@article{Thabit2026,
author = {Thabit, Dina Moustafa and Thabet, Dalia M},
title = {Clinical utility and prognostic value of GATA3 in epithelioid malignant mesothelioma: a practical and cost-effective approach for resource-limited settings},
journal = {Journal of Clinical Pathology},
year = {2026},
volume = {79},
number = {7},
pages = {475--485},
doi = {10.1136/jcp-2026-210673}
}
EUVIMED